Knee pain and severity were linked to quadriceps weakness over time but had no impact on the rate of deterioration among patients with or at risk for knee OA.

Women with systemic sclerosis face increased risks for adverse pregnancy outcomes, with certain risks being elevated even before diagnosis.

Men with weakness or tension in their pelvic floor may present with a variety of symptoms that negatively affect their ...

Increased MetS severity was independently associated with a greater risk for frailty among individuals with RA.

The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome ...

Hormonal changes associated with menopause may influence the clinical presentation of systemic sclerosis (SSc), according to study findings published in Therapeutic Advances in Musculoskeletal Disease ...

Cemdisiran is a subcutaneously-administered, small interfering RNA therapeutic that reduces the production of complement factor 5 in the liver.

BoneXpert and IB-lab-PANDA demonstrated accurate bone age evaluations against manual ratings among pediatric patients with GHD.

Interquartile range increase in the cumulative exposure to heatwaves were associated with 0.023- to 0.031-year increases in biological age.

Oral semaglutide was linked to reduced SU levels among patients with T2D, particularly among individuals with hyperuricemia and those who switched from a DPP-4 inhibitor.

Using longitudinal MRI radiomics, biochemical biomarkers, and clinical factors improves prediction of progression in knee OA.

Very abnormal laboratory results were often already known or suspected or thought to be unrelated to DMARD use in RA.